Cumberland Pharmaceuticals (CPIX) Capital Expenditures Growth (1y) (2011 - 2025)
Cumberland Pharmaceuticals (CPIX) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 32.98% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -21.54% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -100.04% |
| Sep 30, 2025 | 54.68% |
| Jun 30, 2025 | 268.99% |
| Mar 31, 2025 | 14.44% |
| Dec 31, 2024 | -95.31% |
| Sep 30, 2024 | -71.06% |
| Jun 30, 2024 | -90.06% |
| Mar 31, 2024 | -61.20% |
| Dec 31, 2023 | 131.70% |
| Sep 30, 2023 | -41.88% |
| Jun 30, 2023 | -47.40% |
| Mar 31, 2023 | 297.47% |
| Dec 31, 2022 | -1,797.00% |
| Sep 30, 2022 | 52.51% |
| Jun 30, 2022 | 810.60% |
| Mar 31, 2022 | 38.69% |
| Dec 31, 2021 | -80.17% |
| Sep 30, 2021 | 35.32% |
| Jun 30, 2021 | -46.47% |
| Mar 31, 2021 | -14.38% |